Long-term use of the newer anti-clotting drug Brilinta cut heart attack survivors’ future risk of heart attack, stroke or heart-related death, a new study found. Marc Sabatine, a professor of medicine at Brigham and Women’s Hospital, led the study.
Trending News
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
New AI Tool Predicts Risk of More Than 300 Diseases With Existing Patient Data
Machine learning reveals complex patterns that can guide care and research